← Back to headlines
MoonLake Immunotherapeutics CFO Sells 39,000 Shares
The Chief Financial Officer of MoonLake Immunotherapeutics has sold 39,000 shares of the company, as reported in a recent transaction.
3 Jul, 14:34 — 3 Jul, 14:34
Sources
Showing 1 of 1 sources
